Ohio State Navbar

Directory

Cebulla, Colleen


Colleen Cebulla, MD, PhD
Retina Division / Ocular Oncology Division
Associate Professor

Specialty/Research Interests
Ocular Oncology, Retinal Detachments, Proliferative Vitreoretinopathy, Uveal Melanoma, Hypoxia, Vascular Biology


Meet Dr. Cebulla


Training

•  BA - Macalester College in St. Paul, MN
•  PhD - The Ohio State University in Columbus, OH
•  MD - The Ohio State University in Columbus, OH
•  Residency - Bascom Palmer Eye Institute in Miami, FL
•  Retina Fellowship - Bascom Palmer Eye Institute in Miami, FL
•  Ocular Oncology Fellowship - Bascom Palmer Eye Institute in Miami, FL


Biography

Dr. Cebulla is Board Certified in Ophthalmology and serves as Professor at OSU, specializing in Vitreoretinal Diseases and Ocular Oncology. She serves as the Assistant Director of the Retina Division and directs the Retina Research Laboratory for the department. She was President of the Columbus Eye Ear Nose Throat Society and is in the Retina Society.  She has received other honors including Best Doctors in America. She is a regular volunteer for the Columbus Free Clinic.

In addition to seeing patients, Dr. Cebulla is actively engaged in both basic and clinical research.  The focus of Dr. Cebulla's lab is translational research on retinal detachments and uveal melanoma.  She has developed two retinal detachment animal models through proteomic studies and has identified promising treatments for potential therapeutics.

She is conducting a clinical project on gene polymorphisms which may be associated with the development of retinal fibrosis, which plays a role in eye diseases from macular degeneration to diabetes.  She is particularly interested in the role of inflammation and macrophage subtype in scar formation and photoreceptor cell death in retinal detachments.

Also, she is involved in a collaborative group with Dr. Mohammed Abdel-Rahman and Dr. Frederick Davidorf which has identified that over 10% of patients with uveal melanoma have an inheritable cancer syndrome. They are working to identify the genes responsible for an increased chance of cancer in families and have identified a new cancer syndrome due to mutation in the BAP1 gene. They are currently involved in understanding factors which influence survival with metastatic disease and on targeted therapy for melanoma.


Contact Information

E-mail: Colleen.Cebulla@osumc.edu

OSU Phone: (614) 293-8041
OSU Address: 915 Olentangy River Rd, Ste 5000, Columbus, OH 43212
 
Dublin Phone: (614) 761-7000
Dublin Fax: (614) 761-7530
Dublin Address: 6435 Post Rd, Dublin, OH 43016